Ki-67 is a prognostic parameter in breast cancer patients: results of a large population-based cohort of a cancer registry

Prognostic relevance of Ki-67 in the primary tumor for survival after a diagnosis of distant metastasis

(2013) Christian R. Loehberg et al.   BREAST CANCER RESEARCH AND TREATMENT

Correlation between Ki67 and Breast Cancer Prognosis

(2013) Konstantinos Kontzoglou et al.   ONCOLOGY

Validity of the proliferation markers Ki67, TOP2A, and RacGAP1 in molecular subgroups of breast cancer

(2012) Karin Milde-Langosch et al.   BREAST CANCER RESEARCH AND TREATMENT

Prognostic Value of Breast Cancer Subtypes, Ki-67 Proliferation Index, Age, and Pathologic Tumor Characteristics on Breast Cancer Survival in Caucasian Women

(2012) N. Lynn Ferguson et al.   Breast Journal

Advances in Breast Cancer – Looking Back over the Year

(2012) D. Lüftner et al.   GEBURTSHILFE UND FRAUENHEILKUNDE

Biomarkers in Breast Cancer – An Update

(2012) M. Schmidt et al.   GEBURTSHILFE UND FRAUENHEILKUNDE

Breast Cancer 2012 - New Aspects

(2012) H.-C. Kolberg et al.   GEBURTSHILFE UND FRAUENHEILKUNDE

Strategies for subtypes—dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011

(2011) A. Goldhirsch et al.   ANNALS OF ONCOLOGY

Ki-67: level of evidence and methodological considerations for its role in the clinical management of breast cancer: analytical and critical review

(2011) Elisabeth Luporsi et al.   BREAST CANCER RESEARCH AND TREATMENT

Zurich Consensus: Statement of German Experts on St. Gallen Conference 2011 on Primary Breast Cancer (Zurich 2011)

(2011) Michael Untch et al.   Breast Care

St. Gallen 2011: Summary of the Consensus Discussion

(2011) Michael Gnant et al.   Breast Care

Prognostic Value of a Combined Estrogen Receptor, Progesterone Receptor, Ki-67, and Human Epidermal Growth Factor Receptor 2 Immunohistochemical Score and Comparison With the Genomic Health Recurrence Score in Early Breast Cancer

(2011) Jack Cuzick et al.   JOURNAL OF CLINICAL ONCOLOGY

Assessment of Ki67 in Breast Cancer: Recommendations from the International Ki67 in Breast Cancer Working Group

(2011) M. Dowsett et al.   JNCI-Journal of the National Cancer Institute

Personalized treatment of early-stage breast cancer: Present concepts and future directions

(2010) Nadia Harbeck et al.   CANCER TREATMENT REVIEWS

Ki67 in breast cancer: prognostic and predictive potential

(2010) Rinat Yerushalmi et al.   LANCET ONCOLOGY

Ki-67 as a prognostic molecular marker in routine clinical use in breast cancer patients

(2009) Folkward G. Wiesner et al.   BREAST

Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast Cancer

(2009) Maggie C. U. Cheang et al.   JNCI-Journal of the National Cancer Institute

Proliferation markers and survival in early breast cancer: A systematic review and meta-analysis of 85 studies in 32,825 patients

(2008) R. Stuart-Harris et al.   BREAST

Development of the 21-Gene Assay and Its Application in Clinical Practice and Clinical Trials

(2008) Joseph A. Sparano et al.   JOURNAL OF CLINICAL ONCOLOGY

Clinical Application of the 70-Gene Profile: The MINDACT Trial

(2008) Fatima Cardoso et al.   JOURNAL OF CLINICAL ONCOLOGY

Prognostic and Predictive Value of Centrally Reviewed Ki-67 Labeling Index in Postmenopausal Women With Endocrine-Responsive Breast Cancer: Results From Breast International Group Trial 1-98 Comparing Adjuvant Tamoxifen With Letrozole

(2008) Giuseppe Viale et al.   JOURNAL OF CLINICAL ONCOLOGY

Predictive Value of Tumor Ki-67 Expression in Two Randomized Trials of Adjuvant Chemoendocrine Therapy for Node-Negative Breast Cancer

(2008) Giuseppe Viale et al.   JNCI-Journal of the National Cancer Institute

Understanding the Molecular Basis of Histologic Grade

(2008) M. Ignatiadis et al.   PATHOBIOLOGY